Do ponto de vista fisiolgico, este fenmeno no inesperado: ao retirar o medicamento, o seu efeito sobre a regulao do apetite e a saciedade desaparece, enquanto os mecanismos biolgicos de defesa do peso corporal so reativados
Using them together could increase the risk of side effects and may not offer extra weight loss benefits
Future Directions For GLP-1 Receptor Agonists Judging from the current research and development trends, long-acting, oral dosage forms and multi-target receptor agonists are the key directions for the future development of GLP-1 receptor agonists
Semaglutide While past research has shown tirzepatide produces greater weight loss than semaglutide in patients with type 2 diabetes, data from head-to-head trials comparing these medications in patients without diabetes are not yet available
Subsequent in vivo work in transected tendon and ligament models has reproduced these findings and added documentation of accelerated collagen deposition, growth-hormone receptor upregulation, and improved biomechanical recovery markers
The two main culprits here are cortisol (the primary stress hormone) and prolactin